Literature DB >> 22330829

Possible influence of a non-synonymous polymorphism located in the NGF precursor on susceptibility to late-onset Alzheimer's disease and mild cognitive impairment.

Emilio Di Maria1, Elisa Giorgio, Vera Uliana, Cristian Bonvicini, Francesca Faravelli, Sergio Cammarata, Maria Cristina Novello, Daniela Galimberti, Elio Scarpini, Orazio Zanetti, Massimo Gennarelli, Massimo Tabaton.   

Abstract

The complex network of neurotrophic factors is supposed to play a role in neurodegeneration, but the effect of variations in their coding genes on susceptibility to sporadic Alzheimer's disease is not established. The mature form of nerve growth factor (NGF) derives from a precursor, proNGF, which was recently discovered to exert crucial functions in brain. We designed a case-control association study to test the hypothesis as to whether polymorphisms located in the proNGF genomic region influence the liability to Alzheimer's disease and its prodromal form, mild cognitive impairment. Three independent case-control samples, with individuals aged >60 years, were collected in Italian Alzheimer Units. One polymorphism located in the proNGF region, rs6330, demonstrated a minor allele frequency >5% and was used in the association study. The minor allele of rs6330 was more frequent in patients from the three sample series as compared to respective normal controls. Multivariate logistic regression showed a significant association under the dominant model in one cohort (OR 1.83, 95% CI 1.00-3.54) and in the pooled case-control sample (OR 1.47, 95% CI 1.03-2.08). These findings further suggest that proNGF may play a role in Alzheimer-type neurodegeneration and that genetic variations in the NGF locus may influence the occurrence of sporadic, late-onset Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22330829     DOI: 10.3233/JAD-2012-112006

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  14 in total

1.  Association of OGG1 and DLST promoter methylation with Alzheimer's disease in Xinjiang population.

Authors:  Wei Chen; Xiaohui Zhou; Yali Duan; Ting Zou; Guili Liu; Xiuru Ying; Qinwen Wang; Shiwei Duan
Journal:  Exp Ther Med       Date:  2018-07-26       Impact factor: 2.447

2.  Rare variants in the neurotrophin signaling pathway implicated in schizophrenia risk.

Authors:  Thorsten M Kranz; Ray R Goetz; Julie Walsh-Messinger; Deborah Goetz; Daniel Antonius; Igor Dolgalev; Adriana Heguy; Marco Seandel; Dolores Malaspina; Moses V Chao
Journal:  Schizophr Res       Date:  2015-07-26       Impact factor: 4.939

Review 3.  The Emerging Therapeutic Role of NGF in Alzheimer's Disease.

Authors:  Chao-Jin Xu; Jun-Ling Wang; Wei-Lin Jin
Journal:  Neurochem Res       Date:  2016-01-22       Impact factor: 3.996

Review 4.  Nerve growth factor and Alzheimer's disease: new facts for an old hypothesis.

Authors:  Antonino Cattaneo; Pietro Calissano
Journal:  Mol Neurobiol       Date:  2012-09-01       Impact factor: 5.590

5.  Presence of proNGF-sortilin signaling complex in nigral dopamine neurons and its variation in relation to aging, lactacystin and 6-OHDA insults.

Authors:  Yi Xia; Bei-Yu Chen; Xiao-Long Sun; Li Duan; Guo-Dong Gao; Jing-Jie Wang; Ken Kam-Lin Yung; Liang-Wei Chen
Journal:  Int J Mol Sci       Date:  2013-07-08       Impact factor: 5.923

6.  LPS-induced proNGF synthesis and release in the N9 and BV2 microglial cells: a new pathway underling microglial toxicity in neuroinflammation.

Authors:  Li Duan; Bei-Yu Chen; Xiao-Long Sun; Zhuo-Jing Luo; Zhi-Ren Rao; Jing-Jie Wang; Liang-Wei Chen
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

7.  Association of brain-derived neurotrophic factor and nerve growth factor gene polymorphisms with susceptibility to migraine.

Authors:  Salih Coskun; Sefer Varol; Hasan H Ozdemir; Elif Agacayak; Birsen Aydın; Oktay Kapan; Mehmet Akif Camkurt; Saban Tunc; Mehmet Ugur Cevik
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-19       Impact factor: 2.570

8.  Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer's Disease: Implications for the Treatment.

Authors:  Paolo Bosco; Raffaele Ferri; Maria Grazia Salluzzo; Sabrina Castellano; Maria Signorelli; Ferdinando Nicoletti; Santo Di Nuovo; Filippo Drago; Filippo Caraci
Journal:  Curr Genomics       Date:  2013-04       Impact factor: 2.236

9.  Nerve growth factor and its receptor in schizophrenia.

Authors:  Roksana Zakharyan; Sofi Atshemyan; Anaida Gevorgyan; Anna Boyajyan
Journal:  BBA Clin       Date:  2014-05-20

10.  The regulated secretory pathway and human disease: insights from gene variants and single nucleotide polymorphisms.

Authors:  Wei-Jye Lin; Stephen R Salton
Journal:  Front Endocrinol (Lausanne)       Date:  2013-08-06       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.